602 related articles for article (PubMed ID: 14203273)
1. CLINICAL EFFECTS OF A NEW, POTENT, NON-TOXIC SULFONYLUREA (TOLAZAMIDE).
GRINNELL EH; SKILLMAN TG; BARSE R; MOLLER CL
Curr Ther Res Clin Exp; 1964 Jul; 6():433-41. PubMed ID: 14203273
[No Abstract] [Full Text] [Related]
2. [ON TOLAZAMIDE: APROPOS OF A NEW HYPOGLYCEMIC SULFANYLUREA AND OF ACQUIRED SULFANYLUREAU RESISTANCE].
KLINGER R; DALLECOSTE P
Minerva Med; 1964 Jul; 55():2237-40. PubMed ID: 14179829
[No Abstract] [Full Text] [Related]
3. ORAL HYPOGLYCEMIC DRUGS: COMPARATIVE EVALUATION OF TOLBUTAMIDE, CHLORPROPAMIDE AND PHENFORMIN.
MOSS JM; DELAWTER DE; GALLAGHER EJ
Med Times; 1964 Jul; 92():645-54. PubMed ID: 14184191
[No Abstract] [Full Text] [Related]
4. HYPOGLYCEMIC COMA DURING SULFONYLUREA THERAPY.
BERGMAN H
Acta Med Scand; 1965 Mar; 177():287-98. PubMed ID: 14281786
[No Abstract] [Full Text] [Related]
5. TOLAZAMIDE (TOLANASE) -- A NEW SULPHONYLUREA.
BECKETT AG; DONOVAN RJ
Br J Clin Pract; 1965 May; 19():275-9. PubMed ID: 14286139
[No Abstract] [Full Text] [Related]
6. [CLINICAL EXPERIENCES WITH A NEW ORAL HYPOGLYCEMIC DRUG, ACETOHEXAMIDE].
CHANIS RA
Arch Med Panamenos; 1963 Dec; 12():193-206. PubMed ID: 14161953
[No Abstract] [Full Text] [Related]
7. CLINICAL STUDIES OF TOLAZAMIDE AND TOLBUTAMIDE: COMPARATIVE EFFECTIVENESS OF CONTROL OF DIABETES MELLITUS.
RENNIE CS; ANDERSON DO
Can Med Assoc J; 1963 Sep; 89(13):669-71. PubMed ID: 14077815
[TBL] [Abstract][Full Text] [Related]
8. [CLINICAL EVALUATION OF A NEW HYPOGLYCEMIC AGENT WITH CHOLESTEROLEMIC ACTION (TOLAZAMIDE). PRELIMINARY REPORT].
ROJAS L; COLINABRACHO L; DOMENGE L
Rev Invest Clin; 1964; 16():173-82. PubMed ID: 14170236
[No Abstract] [Full Text] [Related]
9. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
Prendergast BD
Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
[TBL] [Abstract][Full Text] [Related]
10. [CLINICAL OBSERVATIONS DONE WITH ACETOHEXAMIDE IN THE ORAL TREATMENT OF DIABETES MELLITUS IN THE ADULT].
PAES E; SILVAGOMES FJ; CANAS MA
Rev Iber Endocrinol; 1964; 11():5-17. PubMed ID: 14134258
[No Abstract] [Full Text] [Related]
11. EVALUATION OF TOLAZAMIDE IN THE TREATMENT OF DIABETES MELLITUS.
BRESSLER R; KATZ R
Curr Ther Res Clin Exp; 1965 Apr; 7():219-25. PubMed ID: 14276012
[No Abstract] [Full Text] [Related]
12. [ACTION OF HYPOGLYCEMIC SULFONAMIDES ON THE PRODUCTION OF CO2 BY ADIPOSE TISSUE OF THE RAT EPIDIDYMIS "IN VITRO"].
MARQUES M; RIETCORREA P
Folia Endocrinol; 1964 Jun; 17():381-6. PubMed ID: 14210726
[No Abstract] [Full Text] [Related]
13. METABOLISM OF ANTIDIABETIC SULFONYLUREAS IN MAN. I. BIOLOGICAL HALF-LIVES OF THE P-ACETYLBENZENESULFONYLUREAS, U-18536 AND ACETOHEXAMIDE AND THEIR METABOLITES.
SMITH DL; VECCHIO TJ; FORIST AA
Metabolism; 1965 Mar; 14():229-40. PubMed ID: 14261407
[No Abstract] [Full Text] [Related]
14. ACETOHEXAMIDE ('DIMELOR') IN DIABETES.
HERMAN M; JACKSON WP
S Afr Med J; 1964 Jul; 38():519-22. PubMed ID: 14182168
[No Abstract] [Full Text] [Related]
15. ORAL MEDICATION IN DIABETES.
SCHUSTER F
J Am Inst Homeopath; 1964; 57():241-6. PubMed ID: 14216362
[No Abstract] [Full Text] [Related]
16. ACETOHEXAMIDE: CLINICAL EVALUATION OF A NEW ORAL ANTIDIABETIC AGENT.
ALTERMAN SL; LIEBER AL
Curr Ther Res Clin Exp; 1964 Mar; 6():148-55. PubMed ID: 14131413
[No Abstract] [Full Text] [Related]
17. CLINICAL STUDY OF TOLAZAMIDE: A NEW ANTIDIABETIC SULFONYLUREA.
STERN SB
J La State Med Soc; 1965 Jun; 117():198-202. PubMed ID: 14292548
[No Abstract] [Full Text] [Related]
18. COMBINED TRIAL OF ACETOHEXAMIDE AND TWO DIGUANIDE PREPARATIONS.
SZANTO S
Ir J Med Sci; 1964 Jan; 457():3-11. PubMed ID: 14113902
[No Abstract] [Full Text] [Related]
19. CHOLESTATIC JAUNDICE FOLLOWING USE OF SULFONYLUREA DRUGS.
COLLENS WS; DOBKIN GB
N Y State J Med; 1965 Apr; 65():907-9. PubMed ID: 14265335
[No Abstract] [Full Text] [Related]
20. HYPOTHYROIDISM IN DIABETICS TREATED WITH SULPHONYLUREA.
HUNTON RB; WELLS MV; SKIPPER EW
Lancet; 1965 Sep; 2(7410):449-51. PubMed ID: 14337821
[No Abstract] [Full Text] [Related]
[Next] [New Search]
